Δ9 -Tetrahydrocannabinol promotes functional remyelination in the mouse brain.
Tania AguadoAlba Huerga-GómezAníbal Sánchez-de la TorreEva ReselJuan Carlos CharaCarlos MatuteSusana MatoIsmael Galve-RoperhManuel GuzmanJavier PalazuelosPublished in: British journal of pharmacology (2021)
Overall, our study identifies THC administration as a promising pharmacological strategy aimed to promote functional CNS remyelination in demyelinating disorders.